What is Eli Lilly and Co's current stock price?

View Eli Lilly and Co (LLY)'s real-time stock price, AI-powered analysis, and key financial metrics on Helm Terminal.

Is LLY a good stock to buy?

LLY analysis includes AI-driven insights covering fundamentals, analyst consensus, and market sentiment. Visit Helm Terminal for the full breakdown.

What is Eli Lilly and Co's market cap?

Get Eli Lilly and Co's current market capitalization, P/E ratio, and other key financial metrics with Helm Terminal's free stock analysis tool.

Where can I get free stock analysis for LLY?

Helm Terminal offers free AI-powered stock analysis for LLY, including financial summaries, key metrics, and market insights at helmterminal.dev/analyze/LLY.

LLY Stock Analysis — Helm Terminal

← Back to search

LLYBullish

Eli Lilly and Co

Helm AI

Eli Lilly's stock currently trades at $953.3, up 2.39% on the day, buoyed by a remarkable 95.89% year-over-year EPS growth and a staggering 44.70% revenue growth. With a market cap of $900.70B and a robust ROE of 97.85%, the company's strong fundamentals suggest significant upside potential, especially as analysts rate it with 12 Strong Buy recommendations.

Price

$953.30

+2.39%

Market Cap

$900.70B

P/E (TTM)

43.62

EPS Growth YoY

95.89%

Revenue Growth YoY

44.70%

ROE (TTM)

97.85%

Recommendation

Investors should consider a bullish position on Eli Lilly given its impressive growth metrics and strong market presence.

Recent Headlines

New weight-loss pill wins FDA approval as demand surges

2026-04-09

Nxera Pharma Achieves Second Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases

2026-04-08

Eli Lilly (LLY) Ascends But Remains Behind Market: Some Facts to Note

2026-04-08